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Clinical PerspectiveWhat Is New?Arterial stiffness measured by brachial‐ankle pulse wave velocity is associated with incident hypertension according to the updated 2017 American College of Cardiology/American Heart Association High Blood Pressure Guidelines.Women were at higher risk than men with respect to developing hypertension according to brachial‐ankle pulse wave velocity.What Are the Clinical Implications?In middle‐aged people, brachial‐ankle pulse wave velocity could be additively associated with the risk of incident hypertension.

Introduction {#jah34364-sec-0008}
============

Blood pressure is a strong risk factor of cardiovascular events such as coronary heart disease, stroke, and peripheral artery disease.[1](#jah34364-bib-0001){ref-type="ref"}, [2](#jah34364-bib-0002){ref-type="ref"}, [3](#jah34364-bib-0003){ref-type="ref"} Globally, the prevalence of hypertension is predicted to increase to a total of 1.56 billion people.[4](#jah34364-bib-0004){ref-type="ref"} Thus, early detection or prediction of hypertension is important from the perspective that cardiovascular disease is a leading cause of mortality, disability, and global healthcare costs.[5](#jah34364-bib-0005){ref-type="ref"}

Arterial stiffness is one of the earliest detectable manifestations of adverse structural and functional changes within the vessel wall.[6](#jah34364-bib-0006){ref-type="ref"} The relationship between arterial stiffness and hypertension has been reported in several studies.[7](#jah34364-bib-0007){ref-type="ref"}, [8](#jah34364-bib-0008){ref-type="ref"} Blood pressure and vascular stiffness are interdependent. Increased blood pressure can damage blood vessels and accelerate vascular stiffness, and arterial stiffening increases pressure pulsatility and systolic blood pressure.[9](#jah34364-bib-0009){ref-type="ref"} Pulse wave velocity (PWV) is a reliable and noninvasive tool for measuring arterial stiffness. In addition, PWV is a reproducible, accurate, and negative prognostic factor of arterial stiffness.[10](#jah34364-bib-0010){ref-type="ref"}, [11](#jah34364-bib-0011){ref-type="ref"}, [12](#jah34364-bib-0012){ref-type="ref"} Although carotid‐femoral PWV has traditionally been widely used to identify associations with cardiovascular disease such as coronary artery disease, brachial‐ankle pulse wave velocity (baPWV) has also become more widely used in recent years.[13](#jah34364-bib-0013){ref-type="ref"}, [14](#jah34364-bib-0014){ref-type="ref"}, [15](#jah34364-bib-0015){ref-type="ref"}

The American College of Cardiology/American Heart Association (ACC/AHA) recently released revised guidelines for hypertension with lower blood pressure thresholds compared with previous guidelines (systolic blood pressure ≥130 versus 140 mm Hg or diastolic blood pressure ≥80 versus 90 mm Hg).[16](#jah34364-bib-0016){ref-type="ref"}, [17](#jah34364-bib-0017){ref-type="ref"} These changes are expected to increase the prevalence of patients with hypertension, especially in higher‐risk populations compared with the general population.[18](#jah34364-bib-0018){ref-type="ref"}

Although carotid‐femoral PWV is the gold standard for estimating arterial stiffness,[19](#jah34364-bib-0019){ref-type="ref"}, [20](#jah34364-bib-0020){ref-type="ref"} baPWV has recently been reported to be correlated with carotid‐femoral PWV.[15](#jah34364-bib-0015){ref-type="ref"}, [21](#jah34364-bib-0021){ref-type="ref"} In addition, baPWV is easy to measure, requiring no special techniques or training. In this study, we evaluated the relationship between arterial stiffness as measured by baPWV and incident hypertension based on revised guidelines. We assessed whether an increase in PWV could predict the onset of hypertension.

Methods {#jah34364-sec-0009}
=======

Study Subjects {#jah34364-sec-0010}
--------------

The study population consisted of individuals registered in a comprehensive health screening program at Kangbuk Samsung Hospital, Seoul and Suwon, Korea. The purpose of the comprehensive health screening program was to improve health through early detection of chronic diseases and associated risk factors. This study analyzed people who, between 2010 and 2016, underwent baPWV testing as a part of their health‐screening examination (Figure [1](#jah34364-fig-0001){ref-type="fig"}). Of the 17 665 individuals for which baPWV and associated data were initially available, we applied the following exclusion criteria: history of hypertension (n=4533); history of malignancy (n=861); history of cardiac surgery or cardiovascular disease (n=636); taking medicine for hypertension, diabetes mellitus, hyperlipidemia, or stroke (n=156); and age \<0020 years (n=6). Finally, a total of 10 360 participants were eligible for inclusion in our study (7836 men and 2536 women; mean age, 40.2±7.2 years). The study protocol was approved by the Institutional Review Board of Kangbuk Samsung Hospital. Written informed consent was obtained from all participants. Data supporting the findings of this study are available from the corresponding author upon request.

![Flowchart summarizing the study population. BP indicates blood pressure.](JAH3-8-e013019-g001){#jah34364-fig-0001}

Data Collection {#jah34364-sec-0011}
---------------

All examinations were conducted at Kangbuk Samsung Health Screening Center clinics in Seoul and Suwon according to a standardized protocol. Blood was drawn from participants after fasting for at least 10 hours and analyzed at the Laboratory Medicine Department at the Kangbuk Samsung Hospital accredited by the Korean Association of Quality Assurance for Clinical Laboratories. Anthropometric measurements including height, weight, systolic blood pressure, and diastolic blood pressure were performed by well‐trained examiners. Blood pressure was measured using an automated oscillometric device (53 000, Welch Allyn, New York) by trained nurses while participants were in a sitting position with their arm supported at heart level after a 5‐minute rest. We recorded 3 consecutive blood pressure readings and used the average of the second and third readings for our analysis. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.

Information about alcohol consumption (type of alcohol and glasses/day), smoking (never smoker, former smoker, or current smoker), frequency of vigorous exercise per week, and level of education were obtained from self‐questionnaires. The baPWV measurement was recorded relative to conventional blood pressure at the same baseline clinic visit.

BaPWV measurements recorded in the supine position were obtained using a volume‐plethysmography device (VP‐1000, OMRON, Kyoto, Japan), which measures both brachial and posterior tibial artery pressure waveforms using an oscillometric method with cuffs placed around both arms and ankles of the participant. baPWV was calculated automatically by time‐phase analysis, and the distance between the upper arm and ankle was estimated based on height. baPWV was obtained from right and left measurements, and the higher of the 2 readings were used for analysis.[22](#jah34364-bib-0022){ref-type="ref"}

Prior history of surgery, drug, cerebrovascular disease, hypertension, hyperlipidemia, and diabetes mellitus was obtained by questionnaires. Hypertension was defined by systolic blood pressure ≥130 mm Hg, diastolic blood pressure ≥80 mm Hg, or current use of anti‐hypertension medication.[16](#jah34364-bib-0016){ref-type="ref"}

Statistical Analysis {#jah34364-sec-0012}
--------------------

Comparisons of baseline characteristics and cardiovascular risk factors of the participants according to hypertension was performed using the following analysis method. Categorical variables are expressed as the number (%) and compared using the Pearson Chi‐squared test. Continuous variables were expressed as mean (standard deviation) or median (interquartile range) if not normally distributed. For continuous variables, Student *t‐*test or Mann--Whitney test were used to compare 2 groups, and ANOVA or Kruskal--Wallis tests were used for comparison of multiple groups as appropriate.

The final number of study participants without hypertension was categorized into 4 groups by baPWV. Cox proportional hazard analysis model was used to estimate adjusted hazard ratios (aHRs) and 95% CI for incident hypertension, adjusted for confounding factors identified from baseline characteristics. The predictive accuracy of each Cox model was determined by Harrell c‐index.[23](#jah34364-bib-0023){ref-type="ref"}

For analyses separated by sex and baPWV quartiles, we estimated aHRs for incident hypertension comparing the 3 highest quartiles of baPWV to the lowest quartile (reference group). In our analyses, we used 4 models to adjust for confounding factors: model 1 was adjusted for age, medical center, year of screening examination, smoking status, alcohol intake, vigorous exercise frequency and education level; model 2 was further adjusted for BMI; model 3 was further adjusted for systolic blood pressure; and model 4 was further adjusted for diastolic blood pressure.

We used Kaplan--Meier estimates to evaluate event rates over time according to baPWV quartiles, and used the log‐rank test for analysis. The interaction effect between variables was also measured. All *P* values were 2‐tailed, and *P*\<0.05 was considered statically significant. Finally, we used receiver operating characteristic analysis to determine the baPWV cut point for incident hypertension. Statistical analyses were performed using Stata version 15.0 (Stata Corp. 2017, College Station, TX).

Results {#jah34364-sec-0013}
=======

We followed 10 360 non‐hypertensive participants over a median period of 2.17 years (interquartile range, 1.74--3.63 years). The mean participant age was 40.2±7.2 years, and 7836 (75.6%) were men. At the end of the follow‐up period, 2000 (19.3%) participants developed hypertension according to the revised 2017 ACC/AHA guidelines.

Table [1](#jah34364-tbl-0001){ref-type="table"} shows the baseline characteristics of the study population including metabolic markers divided into those who develop hypertension compared with those who do not. Participants who developed hypertension were older (42±6.8 versus 39.7±7.2 years) and more obese (BMI, 24.7±2.7 versus 23.1±2.8 kg/m^2^; waist circumference, 86.1±7.5 versus 81.4±8.4 cm). With the exception of high‐density lipoprotein cholesterol levels, all metabolic values were significantly higher in the hypertension group compared with the normotensive group. Compared with the normotensive group, the proportion of current smokers in the hypertension group was greater, while the level of education and the frequency of vigorous exercise was lower. Among participants who developed hypertension, men tended to be older than women (41.2±7.2 versus 37.1±6.2). In addition, systolic and diastolic BP were higher in men than in women (108.9±7.8 versus 98.9±8.6 mm Hg; 69.6±5.7 versus 63.5±6.6 mm Hg, respectively).

###### 

Baseline Characteristics of the Study Cohort Stratified by Incident Hypertension

  Characteristics               No incident Hypertension (n=8360)   Hypertension (n=2000)   *P* Value
  ----------------------------- ----------------------------------- ----------------------- -----------
  Age, y                        39.7±7.2                            42±6.8                  \<0.001
  Sex                                                                                       
  Men                           5941 (71.0)                         1895 (94.7)             \<0.001
  Women                         2419 (28.9)                         105 (5.2)               
  Glucose, mg/dL                92.0 (11.1)                         95.1 (14.7)             \<0.001
  HbA1c, %                      5.55 (0.35)                         5.64 (0.49)             \<0.001
  AST (SGOT), IU/L              22.0 (11.9)                         24.8 (12.6)             \<0.001
  ALT (SGPT), U/L               23.0 (17.9)                         29.1 (24.5)             \<0.001
  GGT, IU/L                     30.5 (30.6)                         45.9 (44.0)             \<0.001
  Triglyceride, mg/dL           110.9 (69.9)                        139.5 (79.6)            \<0.001
  HDL‐C, mg/dL                  56.7 (14.6)                         51.9 (12.4)             \<0.001
  LDL‐C, mg/dL                  120.8 (30.4)                        129.5 (29.5)            \<0.001
  Uric acid, mg/dL              5.4 (1.3)                           6.0 (1.2)               \<0.001
  hsCRP, mg/L                   0.09 (0.28)                         0.11 (0.29)             \<0.001
  Insulin, IU/mL                5.31 (3.06)                         5.94 (3.61)             \<0.001
  HOMA‐IR                       1.23 (0.79)                         1.42 (0.99)             \<0.001
  BMI, kg/m^2^                  23.1 (2.8)                          24.7 (2.7)              \<0.001
  Waist, cm                     81.4 (8.4)                          86.1 (7.5)              \<0.001
  Systolic BP, mm Hg            105.1 (9.0)                         112.3 (6.9)             \<0.001
  Diastolic BP, mm Hg           67.0 (6.3)                          72.7 (4.8)              \<0.001
  Education level                                                                           
  ≥College graduate             7246 (86.6)                         1717 (85.8)             0.02
  ≤High school                  774 (9.2)                           174 (8.7)               
  Unknown                       340 (4.0)                           109 (5.4)               
  Smoking status                                                                            
  Never/former smoker           5858 (70.1)                         1188 (59.4)             \<0.001
  Current smoker                2338 (28.0)                         787 (39.3)              
  Unknown                       164 (2.0)                           25 (1.2)                
  Alcohol, g/day                3.0 (7.0--18.0)                     6.0 (14.0--34.0)        \<0.001
  Vigorous exercise frequency                                                               
  \<1 time/wk                   5163 (61.7)                         1108 (55.4)             \<0.001
  ≥1 time/wk                    3117 (37.2)                         869 (43.4)              
  Unknown                       80 (0.9)                            23 (1.1)                

Data are presented as n (%) or mean±SD or median (interquartile range). ALT indicates alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; GGT, gamma glutamyl transferase; HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment of insulin resistance; hsCRP, high‐sensitivity C‐reactive protein; LDL‐C, low‐density lipoprotein cholesterol; SGOT, serum glutamic‐oxaloacetic transaminase; SGPT, serum glutamate‐pyruvate transaminase.

Tables [2](#jah34364-tbl-0002){ref-type="table"} and [3](#jah34364-tbl-0003){ref-type="table"} show the baseline characteristics of male and female patients in the hypertension population divided into baPWV quartiles. In general, the mean values of the systolic and diastolic blood pressures were highest among patients in the top baPWV quartile. This trend generally held true for other metabolic measurements in the top baPWV quartile as well.

###### 

Baseline Characteristics of the Male Study Cohort Stratified by baPWV Quartile

  Characteristics               PWV Quartiles, cm/s   *P* Value                                                
  ----------------------------- --------------------- ------------------ ------------------ ------------------ ---------
  Age, y                        39.7 (6.4)            40.6 (6.5)         41.3 (6.7)         43.0 (8.4)         \<0.001
  Glucose, mg/dL                92.2 (10.0)           93.1 (11.3)        94.8 (14.8)        95.2 (13.9)        \<0.001
  HbA1c, %                      5.55 (0.32)           5.57 (0.35)        5.61 (0.46)        5.63 (0.47)        \<0.001
  AST (SGOT), IU/L              23.4 (15.5)           23.1 (9.6)         24.2 (13.7)        24.6 (10.7)        \<0.001
  ALT (SGPT), IU/L              26.2 (23.7)           26.0 (16.6)        27.5 (19.2)        28.7 (19.4)        \<0.001
  GGT, IU/L                     34.5 (35.5)           37.0 (31.5)        40.4 (36.7)        43.4 (40.8)        \<0.001
  Triglyceride, mg/dL           120.0 (69.1)          124.0 (70.2)       132.3 (81.1)       139.1 (83.5)       \<0.001
  HDL‐C, mg/dL                  52.6 (12.2)           52.9 (12.8)        52.2 (12.8)        52.3 (12.5)        0.321
  LDL‐C, mg/dL                  124.9 (29.6)          125.9 (28.9)       128.3 (29.1)       131.0 (30.4)       \<0.001
  Uric acid, mg/dL              6.00 (1.15)           6.01 (1.17)        5.99 (1.18)        6.03 (1.17)        0.720
  hsCRP, mg/L                   0.09 (0.19)           0.10 (0.24)        0.11 (0.33)        0.12 (0.36)        0.006
  Insulin, IU/mL                5.40 (3.24)           5.41 (3.04)        5.58 (3.29)        5.72 (3.31)        0.005
  HOMA‐IR                       1.25 (0.82)           1.26 (0.78)        1.33 (0.93)        1.37 (0.91)        \<0.001
  BMI, kg/m^2^                  24.45 (2.79)          24.16 (2.53)       24.03 (2.58)       23.92 (2.58)       \<0.001
  Waist, cm                     85.3 (7.5)            84.8 (6.8)         84.6 (7.1)         84.6 (7.1)         0.008
  Systolic BP, mm Hg            106.5 (7.9)           108.2 (7.6)        109.6 (7.5)        111.4 (7.5)        \<0.001
  Diastolic BP, mm Hg           67.8 (5.9)            69.3 (5.6)         70.2 (5.4)         71.2 (5.3)         \<0.001
  Education level                                                                                              
  ≥College graduate             1798 (92.4)           1800 (91.7)        1716 (87.7)        1667 (89.0)        \<0.001
  ≤High school                  90 (4.6)              107 (5.4)          141 (7.2)          168 (8.5)          
  Unknown                       57 (2.9)              55 (2.8)           99 (5.0)           138 (6.9)          
  Smoking status                                                                                               
  Never/former smoker           1184 (60.9)           1152 (58.7)        1153 (58.9)        1169 (59.2)        0.059
  Current smoker                743 (38.2)            785 (40.0)         769 (39.3)         764 (38.7)         
  Unknown                       17 (0.8)              25 (1.2)           34 (1.7)           40 (2.0)           
  Alcohol, g/day                4.0 (11.0--23.0)      5.0 (11.0--27.0)   5.0 (11.0--27.0)   5.0 (11.0--27.0)   0.026
  Vigorous exercise frequency                                                                                  
  \<1 time/wk                   1024 (52.6)           1086 (55.3)        1105 (56.4)        1155 (58.5)        0.001
  ≥1 time/wk                    910 (46.7)            850 (43.3)         835 (42.6)         795 (40.2)         
  Unknown                       11 (0.5)              26 (1.3)           16 (0.8)           23 (1.1)           

Data are presented as n (%) or mean±SD or median (interquartile range). ALT indicates alanine aminotransferase; AST, aspartate aminotransferase; baPWV, brachial‐ankle pulse wave velocity; BMI, body mass index; BP, blood pressure; GGT, gamma glutamyl transferase; HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment of insulin resistance; hsCRP, high‐sensitivity C‐reactive protein; LDL‐C, low‐density lipoprotein cholesterol; SGOT, serum glutamic‐oxaloacetic transaminase; SGPT, serum glutamate‐pyruvate transaminase.

###### 

Baseline Characteristics of the Female Study Cohort Stratified by baPWV Quartile

  Characteristics               PWV Quartiles, cm/s   *P* Value                                          
  ----------------------------- --------------------- ---------------- ---------------- ---------------- ---------
  Age, y                        35.0 (4.9)            36.4 (5.4)       37.3 (5.9)       39.9 (7.3)       \<0.001
  Glucose, mg/dL                87.8 (7.4)            88.5 (7.2)       88.5 (7.6)       89.8 (8.8)       0.0001
  HbA1c, %                      5.46 (0.25)           5.49 (0.26)      5.48 (0.26)      5.54 (0.30)      \<0.001
  AST (SGOT), IU/L              17.9 (5.9)            18.4 (6.4)       19.0 (14.3)      19.0 (8.6)       0.100
  ALT (SGPT), IU/L              14.0 (9.5)            14.9 (10.4)      16.0 (24.2)      15.5 (9.7)       0.113
  GGT, IU/L                     15.1 (12.8)           16.0 (12.3)      17.2 (22.7)      18.6 (17.2)      0.001
  Triglyceride, mg/dL           73.0 (32.9)           75.8 (42.5)      75.6 (34.0)      86.7 (44.5)      \<0.001
  HDL‐C, mg/dL                  66.7 (14.6)           66.2 (13.7)      66.9 (14.8)      64.8 (15.0)      0.045
  LDL‐C, mg/dL                  101.7 (24.5)          105.5 (26.8)     105.8 (25.9)     113.7 (29.9)     \<0.001
  Uric acid, mg/dL              4.16 (0.89)           4.18 (0.83)      4.25 (0.85)      4.22 (0.85)      0.322
  hsCRP, mg/L                   0.07 (0.21)           0.07 (0.18)      0.07 (0.21)      0.09 (0.36)      0.243
  Insulin, IU/mL                5.03 (2.89)           5.09 (2.99)      5.04 (2.96)      5.30 (3.25)      0.344
  HOMA‐IR                       1.11 (0.68)           1.13 (0.73)      1.12 (0.73)      1.20 (0.79)      0.145
  BMI, kg/m^2^                  21.47 (2.93)          21.32 (2.72)     21.31 (2.95)     21.68 (2.89)     0.07
  Waist, cm                     74.09 (7.54)          74.20 (7.70)     74.56 (7.84)     75.36 (7.56)     0.014
  Systolic BP, mm Hg            95.6 (7.9)            97.3 (8.0)       99.1 (7.9)       103.8 (8.5)      \<0.001
  Diastolic BP, mm Hg           60.8 (6.1)            62.4 (6.3)       63.9 (6.1)       66.8 (6.3)       \<0.001
  Education level                                                                                        
  ≥College graduate             509 (81.4)            494 (78.9)       515 (80.5)       464 (73.1)       0.003
  ≤High school                  98 (15.6)             105 (16.7)       95 (14.8)        144 (22.7)       
  Unknown                       18 (2.8)              27 (4.3)         29 (4.5)         26 (4.1)         
  Smoking status                                                                                         
  Never/former smoker           605 (96.8)            602 (96.1)       597 (93.4)       583 (91.9)       0.001
  Current smoker                13 (2.0)              12 (1.9)         17 (2.6)         22 (3.4)         
  Unknown                       7 (1.1)               12 (1.9)         25 (3.9)         29 (4.5)         
  Alcohol, g/day                1.0 (3.0--7.0)        0.0 (3.0--6.0)   0.0 (3.0--6.0)   0.0 (3.0--7.0)   0.422
  Vigorous exercise frequency                                                                            
  \<1 time/wk                   473 (75.6)            481 (76.8)       483 (75.5)       464 (73.1)       0.757
  ≥1 time/wk                    147 (23.5)            137 (21.8)       150 (23.4)       162 (25.5)       
  Unknown                       5 (0.8)               8 (1.2)          6 (0.9)          8 (1.2)          

Data are presented as n (%) or mean±SD or median (interquartile range). ALT indicates alanine aminotransferase; AST, aspartate aminotransferase; baPWV, brachial‐ankle pulse wave velocity; BMI, body mass index; BP, blood pressure; GGT, gamma glutamyl transferase; HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment of insulin resistance; hsCRP, high‐sensitivity C‐reactive protein; LDL‐C, low‐density lipoprotein cholesterol; SGOT, serum glutamic‐oxaloacetic transaminase; SGPT, serum glutamate‐pyruvate transaminase.

The risk of incident hypertension increased progressively across baPWV quartiles in both men and women (Table [4](#jah34364-tbl-0004){ref-type="table"}). In the fully adjusted multivariate models, including adjustments for age, medical center, year of screening examination, smoking status, alcohol intake, exercise, education level, body mass index, systolic blood pressure and diastolic blood pressure, the aHRs (95% CI) for incident hypertension comparing the highest with the lowest quartiles (reference group) of baPWV were 1.64 (1.41--1.89) in men and 12.36 (4.41--34.62) in women, the difference of which was statistically significant. In this result, the aHRs in women have wide CIs, driven in large part by the chosen reference group having only 4 events. Because statistically operating at such small numbers could cause questions about the accuracy of large‐sample approximations that provide the CIs used and *P* value, so we further analyzed baPWV in women by dividing them into 2 groups (Figure [S1](#jah34364-sup-0001){ref-type="supplementary-material"}, Tables [S1](#jah34364-sup-0001){ref-type="supplementary-material"} and [S2](#jah34364-sup-0001){ref-type="supplementary-material"}). As a result, the risk of incident hypertension was 76% higher in the group with higher baPWV than in the group with lower baPWV, which was statistically significant.

###### 

Risk of Incident Hypertension According to baPWV in Men and Women

          Person‐Years   Events (No.)   Incident Rate (10 000 person‐years)   Age‐Adjusted HR (95% CI)   Multivariable‐Adjusted HR[a](#jah34364-note-0006){ref-type="fn"} (95% CI)                                               
  ------- -------------- -------------- ------------------------------------- -------------------------- --------------------------------------------------------------------------- --------------------- --------------------- ---------------------
  Men                                                                                                                                                                                                                            
  Q1      5360.3         284            529.8                                 1.00 (reference)           1.00 (reference)                                                            1.00 (reference)      1.00 (reference)      1.00 (reference)
  Q2      5763.7         409            709.6                                 1.27 (1.09--1.48)          1.38 (1.18--1.60)                                                           1.41 (1.21--1.65)     1.32 (1.13--1.54)     1.23 (1.05--1.43)
  Q3      5851.4         527            900.6                                 1.61 (1.39--1.86)          1.72 (1.49--1.99)                                                           1.79 (1.55--2.07)     1.59 (1.37--1.84)     1.45 (1.25--1.68)
  Q4      5835.8         675            1156.6                                2.06 (1.79--2.37)          2.16 (1.88--2.49)                                                           2.28 (1.98--2.62)     1.8 (1.55--2.08)      1.64 (1.41--1.89)
  Women                                                                                                                                                                                                                          
  Q1      1503.8         4              26.5                                  1.00 (reference)           1.00 (reference)                                                            1.00 (reference)      1.00 (reference)      1.00 (reference)
  Q2      1532.2         17             110.9                                 3.81 (1.28--11.34)         3.68 (1.23--10.97)                                                          3.81 (1.28--11.34)    3.68 (1.23--10.97)    4.2 (1.41--12.55)
  Q3      1542.5         22             142.6                                 4.74 (1.63--13.80)         4.98 (1.71--14.56)                                                          4.74 (1.63--13.8)     4.98 (1.71--14.56)    5.12 (1.75--14.98)
  Q4      1525.8         62             406.3                                 11.09 (3.96--31.05)        11.11 (3.97--31.11)                                                         11.09 (3.96--31.05)   11.11 (3.97--31.11)   12.36 (4.41--34.62)

baPWV indicates brachial‐ankle pulse wave velocity; HR, hazard ratio.

Model 1: adjustment for age, medical center, year of screening examination, smoking status, alcohol intake, exercise and educationa level; Model 2: Model 1 and adjustment for BMI; Model 3: Model 2 and adjustment for systolic blood pressure; Model 4: Model 3 and adjustment for diastolic blood pressure.

We used Harrell C‐index to check the predictive power of the model with PWV in the incident hypertension risk, which was 0.823 (95% CI 0.812--0.836) for men and 0.894 (95% CI 0.855--0.934) for women.

The Kaplan--Meier curves for risk of incident hypertension according to baPWV quartiles are shown in Figure [2](#jah34364-fig-0002){ref-type="fig"}. The rate was higher for groups with higher baPWV values in both men and women (*P*\<0.001) (Figure [2](#jah34364-fig-0002){ref-type="fig"}). The results were similar when changing the cutoffs of blood pressure to define hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg; Figure [S2](#jah34364-sup-0001){ref-type="supplementary-material"}, Table [S3](#jah34364-sup-0001){ref-type="supplementary-material"} through [S6](#jah34364-sup-0001){ref-type="supplementary-material"}). The interaction between baseline blood pressure, baPWV, and incident hypertension was illustrated by 2‐dimensional plot by quartiles of baPWV and quartiles of baseline systolic blood pressure (Figure [3](#jah34364-fig-0003){ref-type="fig"}, Table [S7](#jah34364-sup-0001){ref-type="supplementary-material"}).

![Kaplan--Meier Curves for incident hypertension according to baPWV in men and women. baPWV indicates brachial‐ankle pulse wave velocity.](JAH3-8-e013019-g002){#jah34364-fig-0002}

![Incident hypertension rate by quartiles of baPWV and quartiles of baseline systolic blood pressure. baPWV indicates brachial‐ankle pulse wave velocity; SBP, systolic blood pressure; PY, person‐years.](JAH3-8-e013019-g003){#jah34364-fig-0003}

No significant interactions were observed between baPWV and any of the subgroups with respect to the incidence of hypertension, as shown in the hazard‐ratio plots in Figure [4](#jah34364-fig-0004){ref-type="fig"}. In addition, we used the Youden Index on the receiver operating characteristic curve to determine the baPWV cut point for predicting incident hypertension.[24](#jah34364-bib-0024){ref-type="ref"} As a result, the baPWV cut point for predicting incident hypertension was 1319 cm/s for male (sensitivity: 58.5%, specificity: 59.7%) and 1246 cm/s (sensitivity: 69.5%, specificity: 69.5%) for female. The Harrell C‐index was not significantly increased when baPWV is added to a Model 4 in Table [4](#jah34364-tbl-0004){ref-type="table"}.

![Subgroup analyses of incident hypertension according to baPWV. baPWV indicates brachial‐ankle pulse wave velocity; BMI, bone mass index, HOMA‐IR, homeostasis model assessment of insulin resistance; hsCRP, high‐sensitity C‐reactive protein.](JAH3-8-e013019-g004){#jah34364-fig-0004}

Discussion {#jah34364-sec-0014}
==========

The American College of Cardiology/American Heart Association (ACC/AHA) recently released revised guidelines[16](#jah34364-bib-0016){ref-type="ref"} for hypertension. These guidelines consist of lower blood pressure thresholds (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg) than previous guidelines (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg).[25](#jah34364-bib-0025){ref-type="ref"} Adopting the 2017 ACC/AHA high blood pressure guidelines is expected to markedly increase the number of people labeled as having hypertension and treated with medication in both the US and China. Indeed, according to these criteria, more than half of those aged 45 to 75 years in both countries can be considered as hypertensive.[26](#jah34364-bib-0026){ref-type="ref"} Accordingly, the usefulness of previously studied tools may also change as patients with perhaps greater risk than the general population become newly included in high blood pressure groups.

In the present study, we evaluate the relationship between blood pressure and baPWV reflective of arterial stiffness among a large cohort of young and middle‐aged asymptomatic adults. There were 3 main findings of our study. First, baPWV as a measure of arterial stiffness was independently associated with development of hypertension even under the new 2017 ACC/AHA guidelines. Second, we found that women were at higher risk than men with respect to developing hypertension according to baPWV.

We evaluated the association between high blood pressure and baPWV as a representative marker of arterial stiffness.[27](#jah34364-bib-0027){ref-type="ref"} Several studies have utilized PWV as a predictor of cardiovascular disease,[28](#jah34364-bib-0028){ref-type="ref"}, [29](#jah34364-bib-0029){ref-type="ref"}, [30](#jah34364-bib-0030){ref-type="ref"} and carotid‐femoral PWV has traditionally been used as a standard method to evaluate vascular damage and cardiovascular disease. However, several recent studies have also demonstrated the effectiveness and validity of baPWV for vascular damage and cardiovascular disease as well.[15](#jah34364-bib-0015){ref-type="ref"}, [21](#jah34364-bib-0021){ref-type="ref"}, [31](#jah34364-bib-0031){ref-type="ref"}, [32](#jah34364-bib-0032){ref-type="ref"} Importantly, measuring baPWV does not require any specialized techniques, and instead is automatically measured by wrapping cuffs on the brachium and ankle. Because of this simple measurement method, baPWV can be used in health examination programs, resulting in higher utilization as a predictive tool.

Arterial stiffness is one of the earliest detectable manifestations of adverse structural and functional changes within the vessel wall.[6](#jah34364-bib-0006){ref-type="ref"} There are several mechanisms of arterial stiffness, including vascular growth factor expression, calcification, inflammation, and environmental factors.[26](#jah34364-bib-0026){ref-type="ref"}, [33](#jah34364-bib-0033){ref-type="ref"}, [34](#jah34364-bib-0034){ref-type="ref"}, [35](#jah34364-bib-0035){ref-type="ref"} Arterial stiffness increases as a complication of hypertension, whereas more recent studies have shown that arterial stiffness contributes to hypertension. Thus, early diagnosis of arterial stiffness may provide insight into future disease, including hypertension.

Several earlier studies have shown that arterial stiffness is associated with hypertension.[8](#jah34364-bib-0008){ref-type="ref"}, [36](#jah34364-bib-0036){ref-type="ref"}, [37](#jah34364-bib-0037){ref-type="ref"}, [38](#jah34364-bib-0038){ref-type="ref"} However there are limitations, in that the studies were relatively small in number or did not adjust for socioeconomic status. In addition, their study did not utilize the new 2017 ACC/AHA criteria.

The results of our study are consistent with those from previous studies on the association between arterial stiffness and hypertension. The increased risk of incident hypertension in those individuals in the greatest baPWV quartile was the same for both men and women, and this result was maintained even after multivariable adjustment. Some of the strengths of this study relative to prior studies were the relatively large number participants (n=10 360), use of new hypertension guidelines, and adjusting for socioeconomic status.

Study Limitations {#jah34364-sec-0015}
=================

The results of this study should be interpreted in the context of several potential limitations. First, the diagnosis of hypertension were based on measurements taken at a single visit, which may be unreliable and lead to misclassification of blood pressure status. Well‐trained examiners measured blood pressure 3 times using the standard method of measurement, but we cannot completely rule out white coat or masked hypertension that may occur in some patients. The 24‐hour ambulatory BP measurement can be used as a good tool to rule out white coat or masked hypertension. Unfortunately, we didn\'t measure 24‐hour ambulatory BP to confirm hypertension, so we couldn\'t completely rule out the possibility of white coat or masked hypertension. Second, although we adjusted for age, BMI, smoking status, blood pressure, and several other possible risk factors, we could not exclude all possible residual confounding factors. To address this limitation, we performed multivariate analysis to account for confounding factors. Third, there is a notable dispersion at the end of the follow‐up period across baPWV quartiles. When referring to Kaplan Meier plots in Figure [2](#jah34364-fig-0002){ref-type="fig"}, the difference in the number at risk between Q1 and Q4 for men at year 3 is (794--615)/615=29%. However, the absolute difference in cumulative incidence of hypertension between Q1 and Q4 is ≈ 10%. This result can be interpreted as likely to have visited patients in Q4 more frequently, which suggests the possibility of ascertainment bias. The Occupational Safety and Health Act in Korea require employers to conduct annual or biennial health examinations of all employees, and employees are required to participate. About 80 percent of the population who participated in this study were conducted under the Occupational Safety and Health Act in Korea, so there is little room for individual will to intervene. However, since the remaining 20% were the people who underwent medical checkups on their own, it is likely that these people underwent medical checkups more frequently. For this reason, there is a possibility that ascertainment bias has occurred. Fourth, our study consisted of relatively healthy young middle‐aged subjects. Therefore, it may be unreasonable to generalize our results to the entire population. Accordingly, our findings may differ for different age groups or patients from other races/ethnicities beyond Korea. Fifth, we did not measure the heart rate when collecting baPWV results. Heart rate is known as an important confounding factor in interpreting PWV results.[39](#jah34364-bib-0039){ref-type="ref"} Therefore, in this study, it was also necessary to analyze the results by adding heart rate as a covariate to the model. Finally, there is a possibility that the blood pressure measurements may not be an accurate reflection of the true blood pressure and this may influence findings.[40](#jah34364-bib-0040){ref-type="ref"} However, several aspects of this large cohort study add significant strength to our findings. The participants in this study were generally young and healthy, and thus may be less biased to use of medications or co‐morbidities that affect elderly individuals. In addition, the data were collected by well‐trained expert staff according to standardized and uniform conditions.

Conclusions {#jah34364-sec-0016}
===========

We found that baPWV, as a measurement of arterial stiffness, was strongly and independently correlated with hypertension among relatively healthy people. In addition, baPWV was predictive of incident hypertension in patients with known risk factors.
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